Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Stock Soars 17% After Guggenheim Upgrade
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares have suddenly become bullish after it was annouced that Guggenheim upgraded the stock from a “Sell” to a “Buy”, while…